Show pageOld revisionsBacklinksFold/unfold allBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ======= IRF4 ======= == Gene Information == * **<color #00a2e8>Official Symbol</color>**: IRF4 * **<color #00a2e8>Official Name</color>**: interferon regulatory factor 4 * **<color #00a2e8>Aliases and Previous Symbols</color>**: N/A * **<color #00a2e8>Entrez ID</color>**: [[https://www.ncbi.nlm.nih.gov/gene/?term=3662|3662]] * **<color #00a2e8>UniProt</color>**: [[https://www.uniprot.org/uniprot/Q15306|Q15306]] * **<color #00a2e8>Interactions</color>**: [[https://thebiogrid.org/search.php?search=IRF4&organism=9606|BioGRID]] * **<color #00a2e8>PubMed articles</color>**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20IRF4|Open PubMed]] * **<color #00a2e8>OMIM</color>**: [[https://omim.org/entry/601900|Open OMIM]] == Function Summary == * **<color #00a2e8>Entrez Summary</color>**: The protein encoded by this gene belongs to the IRF (interferon regulatory factor) family of transcription factors, characterized by an unique tryptophan pentad repeat DNA-binding domain. The IRFs are important in the regulation of interferons in response to infection by virus, and in the regulation of interferon-inducible genes. This family member is lymphocyte specific and negatively regulates Toll-like-receptor (TLR) signaling that is central to the activation of innate and adaptive immune systems. A chromosomal translocation involving this gene and the IgH locus, t(6;14)(p25;q32), may be a cause of multiple myeloma. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2010]. * **<color #00a2e8>UniProt Summary</color>**: Transcriptional activator. Binds to the interferon- stimulated response element (ISRE) of the MHC class I promoter. Binds the immunoglobulin lambda light chain enhancer, together with PU.1. Probably plays a role in ISRE-targeted signal transduction mechanisms specific to lymphoid cells. Involved in CD8(+) dendritic cell differentiation by forming a complex with the BATF-JUNB heterodimer in immune cells, leading to recognition of AICE sequence (5'-TGAnTCA/GAAA-3'), an immune-specific regulatory element, followed by cooperative binding of BATF and IRF4 and activation of genes (By similarity). {ECO:0000250|UniProtKB:Q64287}. <button type='primary' size='sm' modal='Pfam_Domains'>Pfam Domains</button> <button type='primary' size='sm' modal='GO_terms'>GO Terms</button> <modal id='Pfam_Domains' size='lg' title='Pfam Domains'> |IRF-3| |IRF| </modal> <modal id='GO_terms' size='lg' title='GO Terms'> |regulation of interleukin-13 biosynthetic process| |positive regulation of interleukin-13 biosynthetic process| |positive regulation of interleukin-4 biosynthetic process| |regulation of interleukin-4 biosynthetic process| |positive regulation of interleukin-10 biosynthetic process| |regulation of interleukin-10 biosynthetic process| |T-helper 17 cell lineage commitment| |T-helper 17 cell differentiation| |T-helper 17 type immune response| |T-helper cell lineage commitment| |CD4-positive, alpha-beta T cell lineage commitment| |positive regulation of interleukin-2 biosynthetic process| |alpha-beta T cell lineage commitment| |CD4-positive or CD8-positive, alpha-beta T cell lineage commitment| |nuclear nucleosome| |positive regulation of interleukin-13 production| |myeloid dendritic cell differentiation| |regulation of interleukin-2 biosynthetic process| |T cell lineage commitment| |regulation of interleukin-13 production| |myeloid dendritic cell activation| |defense response to protozoan| |positive regulation of interleukin-4 production| |response to protozoan| |positive T cell selection| |CD4-positive, alpha-beta T cell differentiation involved in immune response| |regulation of interleukin-4 production| |T-helper cell differentiation| |alpha-beta T cell activation involved in immune response| |alpha-beta T cell differentiation involved in immune response| |positive regulation of interleukin-2 production| |T cell differentiation involved in immune response| |dendritic cell differentiation| |regulation of T-helper cell differentiation| |CD4-positive, alpha-beta T cell differentiation| |positive regulation of interleukin-10 production| |T cell selection| |negative regulation of toll-like receptor signaling pathway| |CD4-positive, alpha-beta T cell activation| |regulation of CD4-positive, alpha-beta T cell differentiation| |histone H3 acetylation| |alpha-beta T cell differentiation| |regulation of interleukin-10 production| |regulation of interleukin-2 production| |histone H4 acetylation| |positive regulation of DNA binding| |regulation of CD4-positive, alpha-beta T cell activation| |alpha-beta T cell activation| |regulation of alpha-beta T cell differentiation| |T cell activation involved in immune response| |cellular response to type I interferon| |type I interferon signaling pathway| |positive regulation of cytokine biosynthetic process| |regulation of toll-like receptor signaling pathway| |response to type I interferon| |interferon-gamma-mediated signaling pathway| |regulation of alpha-beta T cell activation| |positive regulation of cold-induced thermogenesis| |regulation of cytokine biosynthetic process| |lymphocyte activation involved in immune response| |myeloid leukocyte differentiation| |histone acetylation| |internal peptidyl-lysine acetylation| |peptidyl-lysine acetylation| |internal protein amino acid acetylation| |regulation of DNA binding| |T cell differentiation| |regulation of T cell differentiation| |regulation of cold-induced thermogenesis| |protein acetylation| |cellular response to interferon-gamma| |regulation of lymphocyte differentiation| |positive regulation of binding| |response to interferon-gamma| |protein acylation| |myeloid cell differentiation| |T cell activation| |lymphocyte differentiation| |cell fate commitment| |regulation of leukocyte differentiation| |adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains| |peptidyl-lysine modification| |regulation of T cell activation| |leukocyte differentiation| |transcription factor binding| |histone modification| |covalent chromatin modification| |regulation of binding| |lymphocyte activation| |sequence-specific DNA binding| |negative regulation of immune system process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |positive regulation of cytokine production| |regulation of hemopoiesis| |regulation of innate immune response| |regulation of immune effector process| |RNA polymerase II proximal promoter sequence-specific DNA binding| |regulation of lymphocyte activation| |regulation of response to biotic stimulus| |hemopoiesis| |myeloid leukocyte activation| |regulation of leukocyte activation| |hematopoietic or lymphoid organ development| |adaptive immune response| |leukocyte activation involved in immune response| |cell activation involved in immune response| |regulation of cell activation| |immune system development| |cytokine-mediated signaling pathway| |DNA-binding transcription factor activity| |regulation of cytokine production| |chromatin organization| |regulation of defense response| |innate immune response| |regulation of multi-organism process| |peptidyl-amino acid modification| |leukocyte activation| |defense response to other organism| |cellular response to cytokine stimulus| |chromosome organization| |cell activation| |immune effector process| |regulation of response to external stimulus| |response to cytokine| |regulation of immune response| |positive regulation of transcription by RNA polymerase II| |negative regulation of signal transduction| |response to other organism| |response to external biotic stimulus| |response to biotic stimulus| |defense response| |negative regulation of cell communication| |negative regulation of signaling| |regulation of response to stress| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |positive regulation of protein metabolic process| |positive regulation of RNA metabolic process| |positive regulation of multicellular organismal process| |positive regulation of molecular function| |regulation of cell differentiation| |immune response| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |membrane| |positive regulation of biosynthetic process| </modal> \\ === CRISPR Data === <button type='primary' size='small' modal='Compound_Hit'>Compound Hit</button> <button type='primary' size='small' modal='Most_Correlated_Genes'>Most Correlated Genes in Chemogenomics</button> <button type='primary' size='small' modal='Essential_Avana'>Tissues where Essential in the Avana Dataset (DepMap 20Q1)</button> <modal id='Compound_Hit' size='lg' title='Compound Hit'> ^Screen^Score^ |[[:results:exp234|Ethanol 0.01 R05 exp234]]|-2.5| |[[:results:exp120|Dimethyl-Sulfoxide 1pc R03 exp120]]|-2.41| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.36| |[[:results:exp116|AICAR 240μM R03 exp116]]|-2.35| |[[:results:exp274|Citral 50μM R06 exp274]]|-2.22| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|-2.22| |[[:results:exp216|Erlotinib 10μM R05 exp216]]|-2.2| |[[:results:exp502|Milciclib 2μM R08 exp502]]|-2.2| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-2.19| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|-2.18| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|-2.13| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-2.02| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|-1.99| |[[:results:exp233|EPZ-5676 30μM R05 exp233]]|-1.84| |[[:results:exp476|Dihydrosphingosine 8μM R08 exp476]]|1.96| </modal> <modal id='Most_Correlated_Genes' size='lg' title='Most Correlated Genes in Chemogenomics'> ^Gene^Correlation^ |[[:human genes:c:csk|CSK]]|0.475| |[[:human genes:p:pag1|PAG1]]|0.412| |[[:human genes:p:pten|PTEN]]|0.4| </modal> <modal id='Essential_Avana' size='lg' title='Tissues where Essential in the Avana Dataset (DepMap 20Q1)'> Global Fraction of Cell Lines Where Essential: 37/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|2/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|6/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|13/15| |prostate|0/1| |skin|4/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| </modal> == Essentiality in NALM6 == * **<color #00a2e8>Essentiality Rank</color>**: 1100 * **<color #00a2e8>Expression level (log2 read counts)</color>**: 7.93 <button type='primary' size='small' modal='Dist_expr'>Expression Distribution</button> <modal id='Dist_expr' size='lg' title='IRF4 Expression in NALM6 Cells: 7.93'> {{:chemogenomics:nalm6 dist.png?nolink |}} </modal> Last modified: 2025/12/10 20:19by 127.0.0.1